Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience

Annals of Surgery

Volumn 253, Issue 4, 2011, Pages 745-758

  Fan, Sheung Tat ^a,b   Mau Lo, Chung ^b   Poon, Ronnie T P ^a,b   Yeung, Chun ^b   Leung Liu, Chi ^b   Yuen, Wai Key ^b   Ming Lam, Chi ^b   Ng, Kelvin K C ^b   Ching Chan, See ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; INTERFERON;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD; CHRONIC HEPATITIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HONG KONG; HOSPITAL MORTALITY; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79953174883     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182111195     Document Type: Article

References (35)

1. Lo CM, Fan ST, Liu CL, et al. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2004;10: 440-447.
2. Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229:322-330.
3. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234:63-70. (Pubitemid 32619336)
4. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176-1181. (Pubitemid 27509300)
5. Fan ST. Liver functional reserve estimation: state of the art and relevance for local treatments: The Eastern perspective. JHepatobiliary Pancreat Sci. 2010;17 380-384.
6. Fan ST. Precise hepatectomy guided by the middle hepatic vein. Hepatobiliary Pancreat Dis Int. 2007;6:430-434.
7. Fan ST. Protection of the liver during partial hepatecotmy. Hepatobiliary Pancreat Dis Int. 2004;3:490-494.
8. Melendez JA, Arslan V, Fischer ME, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998;187:620-625. (Pubitemid 28557801)
9. Liu CL, Fan ST, Lo CM, et al. Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg. 2004;239:194-201.
10. Fan ST, Lo CM, Lai EC, et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med. 1994;331:1547-1552. (Pubitemid 24366901)
11. ReinholdD, Ansorge S, Schleicher ED. Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm Metab Res. 1996;28:267-270. (Pubitemid 26196019)
12. Lai EC, Lo CM, Fan ST et al. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg. 1998;133:183-188. (Pubitemid 28092919)
13. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164-1171. (Pubitemid 34454013)
14. Wu F, Wang ZB, Chen WZ, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005;235:659-667. (Pubitemid 40571111)
15. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg. 1999;16:459-467. (Pubitemid 30072153)
16. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classifi- cation of surgical complications: five-year experience. Ann Surg. 2009;250: 187-196.
17. Sobin LH, Whitekind CH. TNM Classification of Malignant Tumors. 5th ed. New York, NY: John Wiley; 1997.
18. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699. (Pubitemid 26079803)
19. Cherqui D, Laurent A, Mocellin N, et al. Liver resection for transplantable hepatocellular carcinoma: long-termsurvival and role of secondary liver transplantation. Ann Surg. 2009;250:738-746.
20. Belghiti J, Noun R, Malatosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg. 1999;229: 369-375. (Pubitemid 30191772)
21. Fu SY, Lau WY, Li AJ, et al. Liver resection under total vascular exclusion with or without preceding Pringle manoeuvre. Br J Surg. 2010;97:50-55.
22. Yang LY, Fang F, Ou DP, et al. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection. Ann Surg. 2009;249:118-123.
23. Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908-1916. (Pubitemid 351783260)
24. Liu CL, Fan ST, Cheung ST, et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg. 2006;244:194-203. (Pubitemid 44305533)
25. Fan ST, Ng IO, Poon RT, et al. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg. 1999;134:1124-1130. (Pubitemid 29473204)
26. Matsui Y, Terakawa N, Satoi S, et al. Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection. Arch Surg. 2007;142:596-602. (Pubitemid 47080436)
27. Torzilli G, Montorsi M, Donadon M, et al."Radical but conservative" is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg. 2005;201:517-528. (Pubitemid 41393072)
28. Poon RT, Fan ST, Ng IOL, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg. 2000; 231:544-551. (Pubitemid 30185862)
29. Rodriguez-Cuesta J, Vidal-Vanaclocha F, Mendoza L, et al. Effect of asymptomatic natural infections due to common mouse pathogens on the metastatic progression of B16 murine melanoma in C57BL/6 mice. Clin Exp Metastasis. 2005;22:549-558. (Pubitemid 43234639)
30. Tanaka S, Taira K, Kudo A, et al. Anterior approach for left-sided hepatic resection. Hepatogastroenterology. 2008;55:1760-1763.
31. Ikai I, Arii S, OkazakiM, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 2007;37:676-691. (Pubitemid 47054774)
32. Matsumoto A, Tanaka E, Rokuhara A, et al. Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: amulticenter retrospective study of 2795 patients. Hepatol Res. 2005;32:173-184. (Pubitemid 41078655)
33. Ho CL, Chen S, Cheng TK, et al. PET/CT characteristics of isolated bone metastases in hepatocellular carcinoma. Radiology. 2011;258:515-523.
34. Onaca N, Davis GL, Jennings LW, et al. Improved results of transplantation for hepatocellular carcinoma: a report from the international registry of hepatic tumors in liver transplantation. Liver Transpl. 2009;15:574-580.
35. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond theMilan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35-43.